XML 21 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Adjustment
Total Meta Stockholders’ Equity
Total Meta Stockholders’ Equity
Adjustment
Common Stock
Additional Paid-in Capital
Retained Earnings
Retained Earnings
Adjustment
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Noncontrolling interest
Noncontrolling interest
Adjustment
Beginning Balance at Sep. 30, 2020 $ 847,308 $ (10,803) $ 843,705 $ (8,351) $ 344 $ 594,569 $ 234,927 $ (8,351) $ 17,542 $ (3,677) $ 3,603 $ (2,452)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Cash dividends declared on common stock (3,209)   (3,209)       (3,209)          
Issuance of common stock due to ESOP 3,036   3,036   2 3,034            
Repurchases of common stock (86,977)   (86,977)   (27) 27 (84,999)     (1,978)    
Stock compensation 3,592   3,592     3,592            
Total other comprehensive (loss) (4,733)   (4,733)           (4,733)      
Net income 89,167   87,103       87,103       2,064  
Net investment by (distribution to) noncontrolling interests (2,123)                   (2,123)  
Ending Balance at Mar. 31, 2021 835,258   834,166   319 601,222 225,471   12,809 (5,655) 1,092  
Beginning Balance at Dec. 31, 2020 813,210   811,674   326 598,669 198,000   20,119 (5,440) 1,536  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Cash dividends declared on common stock (1,595)   (1,595)       (1,595)          
Repurchases of common stock (30,215)   (30,215)   (7) 7 (30,000)     (215)    
Stock compensation 2,546   2,546     2,546            
Total other comprehensive (loss) (7,310)   (7,310)           (7,310)      
Net income 59,909   59,066       59,066       843  
Net investment by (distribution to) noncontrolling interests (1,287)                   (1,287)  
Ending Balance at Mar. 31, 2021 835,258   834,166   319 601,222 225,471   12,809 (5,655) 1,092  
Beginning Balance at Sep. 30, 2021 871,884   870,729   317 604,484 259,189   7,599 (860) 1,155  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Cash dividends declared on common stock (3,004)   (3,004)       (3,004)          
Issuance of common stock due to ESOP 2,886   2,886   1 2,885            
Repurchases of common stock (146,653)   (146,653)   (24) 24 (143,000)     (3,653)    
Stock compensation 5,524   5,524     5,524            
Total other comprehensive (loss) (76,973)   (76,973)           (76,973)      
Net income 111,408   110,575       110,575       833  
Net investment by (distribution to) noncontrolling interests (1,666)                   (1,666)  
Ending Balance at Mar. 31, 2022 763,406   763,084   294 612,917 223,760   (69,374) (4,513) 322  
Beginning Balance at Dec. 31, 2021 826,156   825,514   301 610,816 217,991   724 (4,318) 642  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Cash dividends declared on common stock (1,482)   (1,482)       (1,482)          
Repurchases of common stock (42,195)   (42,195)   (7) 7 (42,000)     (195)    
Stock compensation 2,094   2,094     2,094            
Total other comprehensive (loss) (70,098)   (70,098)           (70,098)      
Net income 50,102   49,251       49,251       851  
Net investment by (distribution to) noncontrolling interests (1,171)                   (1,171)  
Ending Balance at Mar. 31, 2022 $ 763,406   $ 763,084   $ 294 $ 612,917 $ 223,760   $ (69,374) $ (4,513) $ 322